Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Bimatoprost 0.01% and 0.0125% vs 0.03% in Glaucoma or Ocular Hypertension
NCT00300443Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 2005
- Primary completion
- Jun 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bimatoprost in Glaucoma, ocular hypertension, sponsored by Allergan. Started Dec 2005; status: completed.
02
Drugs
bimatoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00300443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300443.